Application of a novel affinity adsorbent for the capture and purification of recombinant Factor VIII compoundsMCCUE, Justin T; SELVITELLI, Keith; WALKER, Joshua et al.Journal of chromatography. 2009, Vol 1216, Num 45, pp 7824-7830, issn 0021-9673, 7 p.Article

Purification of porcine plasma factor VIII using chromatographic methodsMITICO TANAKA, A; SADAE TANAKA, A; YAGUE LOPES, A. P et al.Biotechnology letters. 2000, Vol 22, Num 4, pp 257-260, issn 0141-5492Article

Recombinate antihaemophilic factorSCOBLE, H. A.Developments in biological standardization. 1998, Num 96, pp 141-147, issn 0301-5149Conference Paper

Hepatitis A viral safety of plasma-derived factor VIII concentrate koate®-HPMITRA, G; DOBKIN, M; DUMAS, M et al.Vox sanguinis (Basel. 1956). 1994, Vol 67, pp 80-82, issn 0042-9007, SUP1Conference Paper

The influence of GAP promoter variants on hirudin production, average plasmid copy number and cell growth in Saccharomyces cerevisiaeJANES, M; MEYHACK, B; ZIMMERMANN, W et al.Current genetics. 1990, Vol 18, Num 2, pp 97-103, issn 0172-8083, 7 p.Article

Characterization of clotting factor IX in plasma-derived preparations by electrophoretic techniquesPOCK, Katharina; BUCHACHER, Andrea; RIZZI, Andreas et al.Journal of chromatography. 2001, Vol 921, Num 1, pp 57-67, issn 0021-9673Conference Paper

Application of monoliths for downstream processing of clotting factor IXBRANOVIC, K; BUCHACHER, A; BARUT, M et al.Journal of chromatography. 2000, Vol 903, Num 1-2, pp 21-32, issn 0021-9673Article

Agglutination of human and animal erythrocytes in marine unicellular algaeLIAO, W.-R; HUANG, R.Journal of industrial microbiology & biotechnology. 2000, Vol 24, Num 4, pp 262-266, issn 1367-5435Article

High expression of a B-domain deleted factor VIII gene in a human hepatic cell lineHERLITSCHKA, S. E; SCHLOKAT, U; FALKNER, F. G et al.Journal of biotechnology. 1998, Vol 61, Num 3, pp 165-173, issn 0168-1656Article

Proteolytic cleavage of recombinant two-chain factor VIII during cell culture production is mediated by protease(s) from lysed cells : The use of pulse labelling directly in production mediumHANSEN, K; KJALKE, M; RASMUSSEN, P. B et al.Cytotechnology (Dordrecht). 1997, Vol 24, Num 3, pp 227-234, issn 0920-9069Article

Hepatitis A virus PCR analysis of clotting factor concentrates and elimination of non-enveloped viruses in their manufactureMOHR, H; LAMBRECHT, B; MARKS, F et al.Vox sanguinis (Basel. 1956). 1994, Vol 67, pp 78-79, issn 0042-9007, SUP1Conference Paper

Production and functional characterization of a recombinant fragment of von Willebrand factor (vWF) : an antagonist to platelet receptro GP IbPRIOR, C; CHU, V; HOLT, J et al.Bio/technology (New York, N.Y. 1983). 1992, Vol 10, Num 1, pp 66-73, issn 0733-222XArticle

Recombinant Human Fibrinogen That Produces Thick Fibrin Fibers with Increased Wound Adhesion and Clot DensityCALCATERRA, Jennifer; VAN COTT, Kevin E; BUTLER, Stephen P et al.Biomacromolecules. 2013, Vol 14, Num 1, pp 169-178, issn 1525-7797, 10 p.Article

Construction, expression, and characterization of recombinant hirudin in Escherichia coliQUN BI; JUNSHAN ZHANG; YIXIU HUANG et al.Applied biochemistry and biotechnology. 2001, Vol 95, Num 1, pp 23-30, issn 0273-2289Article

Expression of human blood clotting factor VIII in the mammary gland of transgenic sheepNIEMANN, H; HALTER, R; CARNWATH, J. W et al.Transgenic research. 1999, Vol 8, Num 3, pp 237-247, issn 0962-8819Article

rtPA is a well-characterized proteinO'CONNOR, J. V.Developments in biological standardization. 1998, Num 96, pp 113-121, issn 0301-5149Conference Paper

PLANIFICATION EXPÉRIMENTALE, APPLICATION AU DÉVELOPPEMENT ET A L'OPTIMISATION DE PROCÉDÉS DE PRODUCTION DE CONCENTRÉS DE PROTÉINES PLASMATIQUES HUMAINES = EXPERIMENTAL RESEARCH METHODOLOGY APPLIED TO THE DEVELOPMENT AND THE OPTIMIZATION OF HUMAN PLASMA PROTEINS PRODUCTION PROCESSESSchuhler, Elisabeth; Cazenave, Jean Pierre.1997, 162 p.Thesis

Current progress in the production of recombinant human fibrinogen in the milk of transgenic animalsBUTLER, S. P; VAN COTT, K; SUBRUMANIAN, A et al.Thrombosis and haemostasis. 1997, Vol 78, Num 1, pp 537-542, issn 0340-6245Conference Paper

A quantitative method for the determination of plasmid copy number in recombinant yeastFUJIMURA, H.-A; SAKUMA, Y; WEIMER, T et al.Biologicals (Print). 1996, Vol 24, Num 1, pp 67-70, issn 1045-1056Article

Removal and inactivation of enveloped and non-enveloped viruses during the purification of a high-purity factor IX by metal chelate affinity chromatographyROBERTS, P. L; WALKER, C. P; FELDMAN, P. A et al.Vox sanguinis (Basel. 1956). 1994, Vol 67, pp 69-71, issn 0042-9007, SUP1Conference Paper

Removal and inactivation of viruses during manufacture of a high purity antihemophilic factor VIII concentrate from human plasmaIN SEOP KIM; YONG WOON CHOI; SUNG RAE LEE et al.Journal of microbiology and biotechnology. 2001, Vol 11, Num 3, pp 497-503, issn 1017-7825Article

Current status of the anticoagulant hirudin: its biotechnological production and clinical practiceSOHN, J. H; KANG, H. A; RAO, K. J et al.Applied microbiology and biotechnology. 2001, Vol 57, Num 5-6, pp 606-613, issn 0175-7598Article

Faster isolation of recombinant factor VIII SQ, with a superporous agarose matrixPALSSON, E; SMEDS, A.-L; PETERSSON, A et al.Journal of chromatography. 1999, Vol 840, Num 1, pp 39-50, issn 0021-9673Article

A simple and rapid method for purifying the extracellular domain of human tissue factorBONING GAO; SHUZHEN LI; THORPE, P. E et al.Thrombosis research. 1998, Vol 91, Num 5, pp 249-253, issn 0049-3848Article

Persistent systemic production of human factor IX in mice by skeletal myoblast-mediated gene transfer : Feasibility of repeat application to obtain therapeutic levelsWANG, J.-M; ZHENG, H; BLAIVAS, M et al.Blood. 1997, Vol 90, Num 3, pp 1075-1082, issn 0006-4971Article